Medically reviewed by Mary Choy, PharmD Farxiga (dapagliflozin) is an orally administered, brand-name medication classified ...

AstraZeneca continues to make the case for its Farxiga diabetes drug, highlighting a cardiology analysis that it hopes will convince more doctors to prescribe it in a highly competitive market.

The Food and Drug Administration (FDA) has approved the following uses for both Jardiance and Farxiga: Jardiance is also ...

Farxiga is one of AZ’s most important drugs, and sales increased by 14% to $726 million in the first half of the year, although this was slower than the growth seen in 2018 when sales grew at 30 ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Earlier this month, a federal judge in Delaware ruled against AstraZeneca’s complaint that sought to halt ongoing negotiations of the price of its diabetes drug, Farxiga (dapagliflozin).